Admera Health is an advanced molecular diagnostics company focused on personalized medicine and non-invasive cancer testing. We are committed to improving the health and well-being of our global community. Using Next Generation Sequencing (NGS), Admera Health is redefining the standard of care for patients in all fields of medicine.Learn More
Developing tests covering prominent diseases that span the continuum of care. Current products include PGxOne™ Plus, CardioGxOne™, AtheroGx™, OncoGxOne™, and OncoGxSelect™. Using innovative technology and uniquely comprehensive tests, Admera Health helps physicians make more educated and informed decisions regarding treatment for their patients. We are constantly improving our products and honing our processes and we pride ourselves on the thorough reporting we are able to perform for each patient’s unique genomic makeup, and tailoring actionable suggestions for doctors and clinicians to implement into their practices. Learn More
Our new product pipeline significantly advances personalized medicine by applying next generation technologies to non-invasive cancer testing and digital health. Keep checking back here periodically as we are continuously updating content and product information.